CHRONIC KIDNEY DISEASE MANAGEMENT IN PRIMARY CARE HANDBOOK REFRESHED FOR HCPs
Breonny Robson, GM Clinical and Research
Kidney Health Australia
Dr Chris Bollen GP, Oakden Medical Centre &
PEAK Committee Member, Kidney Health Australia
Professor Shilpa Jesudason, Nephrologist
Professor of Medicine, University of Adelaide,
Director of Dialysis, Royal Adelaide Hospital &
PEAK Committee Member, Kidney Health Australia
Chris Picton MP, Minister for Health and Wellbeing
Government of South Australia
Kidney Health Australia’s latest kidney disease guide for primary care practitioners is expected to be pivotal in slowing down the rates of kidney failure, which have doubled in the past 20 years and if left unchecked will grow by a further 42% by 2030, according to the health charity.
With specific reference to new kidney treatments and culturally safe kidney care for First Nations Australians, the 5th edition of Chronic Kidney Disease (CKD) Management in Primary Care handbook, known as the ‘kidney bible’, is a significant step-up in enabling earlier diagnosis of kidney disease for GPs and other front-line healthcare professionals.
The number of Australians treated for kidney failure has doubled in the last two decades, causing widespread treatment shortages, increasing costs, and plunging thousands of Australians into highly invasive and life-altering dialysis. With 1.8 million people currently unaware they have kidney disease, this number will only continue to grow.
Breonny Robson, General Manager, Clinical and Research at Kidney Health Australia, said: “The new edition of the GP handbook helps health professionals working in primary care to identify people at risk of CKD in their practice and proactively diagnose CKD. It outlines key strategies to slow the progression of CKD and reduce cardiovascular risk, including simple colour-coded action plans for different stages of the disease.”
Ms Robson added, “It’s an exciting time in CKD care, with new treatments now available that have been shown to slow the progression of CKD to kidney failure by 15 years or more. The handbook contains significant new information on using these medications in people with CKD so that their health outcomes and quality of life can be extended for many years to come.”
The handbook is endorsed by Australian and New Zealand Society of Nephrology (ANZSN), the Renal Society of Australasia (RSA) and the Australian Primary Healthcare Nurses Association (APNA) and Australian College of Rural and Remote Medicine (ACRRM). It has been approved as an Acceptable Clinical Resource by the Royal Australian College of General Practitioners (RACGP).
South Australian Minister of Health and Wellbeing Chris Picton launched the handbook at an event on World Kidney Day, 14th March, at Royal Adelaide Hospital.
The handbook is available from Kidney Health Australia in hardcopy or free download here https://kidney.org.au/health-professionals/ckd-management-handbook
You Might also like
-
Physiotherapy approach to jaw & facial pain ties with dental expertise
Darron Goralsky is the Founder, CEO and Clinical Director of Melbourne TMJ & Facial Pain Centre, one of Australia’s leading multidisciplinary clinics dedicated to the assessment and management of temporomandibular disorders (TMD) and craniofacial pain.
-
Victorian social prescribing program underway
n Part 2 of the Models of Care on Social Prescribing, Australian Health Journal spoke to 4 people involved in the Connect Local program under the Connecting Communities to Care 4 year program. The free program for over 65’s promotes wellbeing through social connection and is underway in the Glen Eira community in Melbourne.
– Deidre McGill, Executive General Manager, At Home Support, Bolton Clarke
– Ann Van Leerdam, Connect Local Community Connector, Bolton Clarke
– Dr Rajna Ogrin, Senior Research Fellow, Bolton Clarke Research Institute, Bolton Clarke - Dr Daniel Fineberg, Deputy Director General Medicine, Alfred Hospital, Victoria -
Thyroid health into pregnancy
‘Without an adequate amount of thyroid hormone mothers can be exposed to hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia or eclampsia, which affect around 10% of pregnant women and are the leading causes of maternal and neonatal mortality worldwide. Mothers who suffer from hypertensive disorders during pregnancy are at increased risk of long-term cardiovascular consequences and hypertensive disorders in subsequent pregnancies. Evidence also indicates a risk of reduced cognitive ability to their offspring.
‘Knowing if you are genetically predisposed to Hashimoto’s or Graves’ Diseases, which are both thyroid autoimmune disorders is important to be aware of, to ensure all appropriate tests are ordered. Autoimmune disorders may predispose mothers to a thyroid problem during pregnancy’, says Professor Creswell Eastman, who also serves as the ATF’s Principal Medical Advisor.